Inmune Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Inmune Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q1 2022.
- Inmune Bio, Inc. Nonoperating Income (Expense) for the quarter ending March 31, 2022 was -$425K, a 5213% decline year-over-year.
- Inmune Bio, Inc. Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was -$1.6M, a 1720% decline year-over-year.
- Inmune Bio, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.19M, a 1020% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)